Home Nucleai

Nucleai

In operation
-
Provider of AI-Driven Precision Oncology Technology Platform

Basic Information

Nucleai: A Spatial Biology Software Platform Operator Dedicated to Precision Medicine, Committed to Transforming Healthcare through Artificial Intelligence. The company's AI-based technology enhances biopsy interpretation via machine learning, creates new precision medicine techniques, and uses computer vision and machine learning algorithms to detect signs of cancer and gastrointestinal diseases, while strengthening drug development support for treatment decisions and improving patients' lives. It enables researchers to discover new, human-interpretable pathology-based biomarkers that predict treatment responses and identify genomic markers or interpret complex biological phenomena on a large scale.
Nucleai Ltd
TelAviv,TelAvivDistrict,Israel
15~50 people
January 01, 2017
pharma@nucleaimd.com